EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Integration of single‐cell and bulk RNA ‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

Zhuofan Mou iD, Lorna W Harries iD

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.13804 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Molecular Oncology, 2025. Verfasst von Zhuofan Mou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, UK. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Epithelial Cells, Prostatic Neoplasms, Sequence Analysis, RNA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prognostic transcriptomic signatures for prostate cancer (PCa) often overlook the cellular origin of expression changes, an important consideration given the heterogeneity of the disorder. Current clinicopathological factors inadequately predict biochemical recurrence, a critical indicator guiding post‐treatment strategies following radical prostatectomy. To address this, we conducted a meta‐analysis of four large‐scale PCa datasets and found 33 previously reported PCa‐associated genes to be consistently up‐regulated in prostate tumours. By analysing single‐cell RNA‐sequencing data, we found these genes predominantly as markers in epithelial cells. Subsequently, we applied 97 advanced machine‐learning algorithms across five PCa cohorts and developed an 11‐gene epithelial expression signature. This signature robustly predicted biochemical recurrence‐free survival (BCRFS) and stratified patients into distinct risk categories, with high‐risk patients showing worse survival and altered immune cell populations. The signature outperformed traditional clinical parameters in larger cohorts and was overall superior to published PCa signatures for BCRFS. By analysing peripheral blood data, four of our signature genes showed potential as biomarkers for radiation response in patients with localised cancer and effectively stratified castration‐resistant patients for overall survival. In conclusion, this study developed a novel epithelial gene‐expression signature that enhanced BCRFS prediction and enabled effective risk stratification compared to existing clinical‐ and gene‐expression‐derived prognostic tools. Furthermore, a set of genes from the signature demonstrated potential utility in peripheral blood, a tissue amenable to minimally invasive sampling in a primary care setting, offering significant prognostic value for PCa patients without requiring a tumour biopsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorEpithelial CellsProstatic NeoplasmsSequence Analysis, RNASingle-Cell AnalysisHumansMaleGene Expression ProfilingGene Expression Regulation, NeoplasticPrognosisTranscriptomeDatasets as Topic

Stichwörter der Autor:innen

bulk RNA‐seqmachine learningprognosisprostate cancersingle‐cell RNA‐seqtumour microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, UK.

ORCID-Profile: Zhuofan Mou, Lorna W Harries

Zitieren

APA

Mou, Z., & Harries, L. W. (2025). Integration of single‐cell and bulk RNA ‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.13804

Vancouver

Mou Z, Harries LW. Integration of single‐cell and bulk RNA ‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer. Molecular Oncology. 2025. doi:10.1002/1878-0261.13804

BibTeX
@article{Mou2025,
  author = {Mou, Zhuofan and Harries, Lorna W},
  title = {Integration of single‐cell and bulk RNA ‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.13804}
}
Kostenlos starten →